New classification: leukaemia subtypes reveal potential of existing drugs
Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present…
Browsing: acute myeloid leukaemia
New maintenance treatment for acute myeloid leukaemia prolongs the lives of patients
Patients with acute myeloid leukaemia (AML), the most common form of acute leukaemia in adults,…
Investigational combo therapy shows benefit for TP53 mutant MDS and AML patients
Myelodysplastic Syndromes (MDS) and acute myeloid leukaemia (AML) are rare haematologic malignancies of the bone…
Palliative care improves quality of life for patients with advanced blood cancer
A first-of-its-kind intervention integrating palliative care early in the course of cancer therapy for patients…
Global trial reveals life saving drug for acute myeloid leukaemia
A landmark paper published today in the New England Journal of Medicine describes the results from a…
ASH 2020: Early phase studies show promise in acute myeloid leukaemia
Eunice Wang, MD, Chief of Leukemia and Director of Infusion Services at Roswell Park Comprehensive…
Young survivors of acute myeloid leukaemia have long-term complications from treatment
Adolescent and young adult (AYA) patients treated for acute myeloid leukaemia (AML) have a high…
Combination therapy improves survival outcomes for patients with acute myeloid leukaemia
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over…
ASH releases new clinical practice guidelines on acute myeloid leukaemia in older adults
ASH have published new guidelines to help older adults with acute myeloid leukaemia (AML) and…
Potential new treatment in acute myeloid leukaemia
Tyrosine kinases are protein enzymes that have many functions within cells, including cell signalling, growth,…